Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 18Terminated 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Prostate Adenocarcinoma 1Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 222pembrolizumab 199Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 153Docetaxel 139Rituximab 137Bevacizumab 137Radiotherapy 136Dexamethasone 126Nivolumab 125Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 62Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × Methods × Clear all
NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
57 enrolled 27 charts
Genitourinary

Prostate Adenocarcinoma

NCT03152526 2020-07-09

CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR

Miltenyi Biomedicine GmbH

Phase NA Terminated
1 enrolled 5 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01057017 2020-02-17

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

Brown University

Phase 2 Terminated
5 enrolled 7 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡